Product information and disease descriptionPlace of product in therapyDisease description
Definition and etiology
8 evidence topics · 4 sources
Definition: recurrent bradykinin-mediated angioedema
“Angioedema is a localized, self-limiting, asymmetric, and disfiguring non-inflammatory edema of the subcutaneous and submucosal tissues that arises because of increased vascular permeability.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“HAE comprises a group of genetic disorders characterized by recurrent episodes of angioedema, inherited across generations and typically mediated by bradykinin.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Classification: HAE with C1-INH deficiency (types 1 and 2) and HAE with normal C1-INH
“HAE (ORPHA:91378, OMIM: PS106100) is most commonly caused by a deficiency of C1 inhibitor (C1-INH), which can be confirmed through biochemical and genetic testing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“It is subclassified into type 1 HAE (quantitative deficiency) and type 2 HAE (dysfunctional protein).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Furthermore, in 2000, a new type of HAE was described in patients with normal C1-INH function, a form initially known as HAE type 3 but currently called HAE with normal C1-INH (HAE-nC1-INH).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Genetic cause: SERPING1 and F12 variants
Penetrance, transmission risk, and de novo variants
“HAE-C1-INH is an autosomal dominant disorder characterized by high penetrance, with only about 5% of mutation carriers remaining asymptomatic over their lifetime.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The risk of parent–child transmission is 50%, but up to 25% of cases result from de novo genetic mutations.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Distribution of HAE types: Swedish population-based cohort
Genetic causes of HAE with normal C1-INH
“Abnormalities in proteins/genes, such as factor XII (encoded by the F12 gene), plasminogen (PLG), angiopoietin-1 (ANGPT1), kininogen 1 (KNG1), myoferlin (MYOF), and heparan sulfate-3-O-sulfotransferase 6 (HS3ST6), have been associated with these forms of HAE (collectively HAE-nC1-INH), and the involvement of bradykinin has not been confirmed in all cases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“HAE of unknown origin (ie, with negative genetic test results) is referred to as HAE-UNK.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“HAE-nC1-INH forms also usually follow an autosomal dominant inheritance pattern, although autosomal recessive forms have been reported.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote